改善印度对高氏病治疗的准入:需要本土制造业
Nidhi Patel1, Heta Pandya, Ganesh Sangle
1Kashiv Biosciences Pvt Ltd, Ahmedabad, India.
Journal of biosciences
|February 22, 2024
概括
印度本土制造高氏病 (GD) 药物可以显著提高治疗的可及性和可负担性. 这种方法解决了进口药物的高成本,使这种罕见的溶酶体储存障碍患者受益.
科学领域:
- 生物医学科学 生物医学科学
- 公共卫生 公共卫生
- 制药科学 制药科学
背景情况:
- 氏病 (Gaucher disease,GD) 是一种流行的溶酶体储存障碍 (LSD),对患者有重大影响.
- 印度对昂贵的进口GD药物的依赖限制了治疗的获取和负担能力.
研究的目的:
- 倡导和探索在印度建立GD药物的本土制造能力.
- 分析进口GD药物的当前挑战,并强调本地化生产的必要性.
主要方法:
- 检查印度GD治疗当前的情况.
- 分析进口GD药物的可用性,负担能力和挑战.
- 探索本土制造业的潜在好处.
主要成果:
- 进口的GD药物价格过高,为印度患者创造了重大进入障碍.
- 本地化生产为降低成本,提高可访问性和提高GD治疗的可用性提供了潜力.
结论:
- 发展国内制造能力对于解决印度GD患者的负担能力和可访问性问题至关重要.
- 本土制造业可以对医疗保健系统,制药业和患者福祉产生积极影响.
- 需要为当地GD药物生产提供可持续的框架,以改善受影响个人的生活.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Good Manufacturing Practices
Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


